Health Innovation Oxford and Thames Valley has voluntarily agreed to publish information about joint working agreements with commercial organisations since April 2021. Listed below are funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in the Health Innovation Oxford and Thames Valley region:
Year 21/22
Novartis Pharmaceuticals UK Ltd: Joint Working Agreement for Heart Failure Business Case collaboration
Year 23/24
AstraZeneca: Sponsorship for Severe Asthma Event 4th July 2023
Sanofi: Sponsorship for Severe Asthma Event 4th July 2023
GSK: Sponsorship for Severe Asthma Event 4th July 2023
Otsuka Pharmaceutical Europe Ltd: Fee for service for Early Stage Market Access Support
Bayer PLC: Fee for service for Development of Wave Health Model
Year 24/25
Otsuka Pharmaceutical Europe Ltd: Fee for service for Operational Pilot for CARE for MDD
Year 25/26
Bayer PLC: Sponsorship for Prostate Cancer Webinar